Intrinsic Value of S&P & Nasdaq Contact Us

Mesoblast Limited MESO NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • AU • USD

SharesGrow Score
39/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.50
-21.3%

Mesoblast Limited (MESO) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, ACHL, ADTX, APGN, APTO, CNTB and others.

MESO has a market capitalization of $1.88B, compared to an average peer market cap of $326.66M. MESO is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message